Cargando…

The effects of dopamine on digit span in Parkinson’s disease

BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Warden, Clara, Hwang, Jaclyn, Marshall, Anisa, Fenesy, Michelle, Poston, Kathleen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/
https://www.ncbi.nlm.nih.gov/pubmed/26955482
http://dx.doi.org/10.1186/s40734-016-0033-z
_version_ 1782419726166654976
author Warden, Clara
Hwang, Jaclyn
Marshall, Anisa
Fenesy, Michelle
Poston, Kathleen L.
author_facet Warden, Clara
Hwang, Jaclyn
Marshall, Anisa
Fenesy, Michelle
Poston, Kathleen L.
author_sort Warden, Clara
collection PubMed
description BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications. Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson’s disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied. Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson’s disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span. METHODS: We recruited 64 Parkinson’s disease patients and 22 age-and education-matched controls. Parkinson’s patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria. RESULTS: Digit Span Backward successfully identified mild cognitive impairment in Parkinson’s disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected. CONCLUSIONS: This study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson’s disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson’s disease patients.
format Online
Article
Text
id pubmed-4780147
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47801472016-03-08 The effects of dopamine on digit span in Parkinson’s disease Warden, Clara Hwang, Jaclyn Marshall, Anisa Fenesy, Michelle Poston, Kathleen L. J Clin Mov Disord Research Article BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications. Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson’s disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied. Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson’s disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span. METHODS: We recruited 64 Parkinson’s disease patients and 22 age-and education-matched controls. Parkinson’s patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria. RESULTS: Digit Span Backward successfully identified mild cognitive impairment in Parkinson’s disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected. CONCLUSIONS: This study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson’s disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson’s disease patients. BioMed Central 2016-03-07 /pmc/articles/PMC4780147/ /pubmed/26955482 http://dx.doi.org/10.1186/s40734-016-0033-z Text en © Warden et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Warden, Clara
Hwang, Jaclyn
Marshall, Anisa
Fenesy, Michelle
Poston, Kathleen L.
The effects of dopamine on digit span in Parkinson’s disease
title The effects of dopamine on digit span in Parkinson’s disease
title_full The effects of dopamine on digit span in Parkinson’s disease
title_fullStr The effects of dopamine on digit span in Parkinson’s disease
title_full_unstemmed The effects of dopamine on digit span in Parkinson’s disease
title_short The effects of dopamine on digit span in Parkinson’s disease
title_sort effects of dopamine on digit span in parkinson’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/
https://www.ncbi.nlm.nih.gov/pubmed/26955482
http://dx.doi.org/10.1186/s40734-016-0033-z
work_keys_str_mv AT wardenclara theeffectsofdopamineondigitspaninparkinsonsdisease
AT hwangjaclyn theeffectsofdopamineondigitspaninparkinsonsdisease
AT marshallanisa theeffectsofdopamineondigitspaninparkinsonsdisease
AT fenesymichelle theeffectsofdopamineondigitspaninparkinsonsdisease
AT postonkathleenl theeffectsofdopamineondigitspaninparkinsonsdisease
AT wardenclara effectsofdopamineondigitspaninparkinsonsdisease
AT hwangjaclyn effectsofdopamineondigitspaninparkinsonsdisease
AT marshallanisa effectsofdopamineondigitspaninparkinsonsdisease
AT fenesymichelle effectsofdopamineondigitspaninparkinsonsdisease
AT postonkathleenl effectsofdopamineondigitspaninparkinsonsdisease